The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2-(3-(5-(hydroxymethyl)furan-2-yl)imidazo[1,5-a]pyridin-1-yl)phenyl)methanol ID: ALA3899458
PubChem CID: 134133716
Max Phase: Preclinical
Molecular Formula: C19H16N2O3
Molecular Weight: 320.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: OCc1ccc(-c2nc(-c3ccccc3CO)c3ccccn23)o1
Standard InChI: InChI=1S/C19H16N2O3/c22-11-13-5-1-2-6-15(13)18-16-7-3-4-10-21(16)19(20-18)17-9-8-14(12-23)24-17/h1-10,22-23H,11-12H2
Standard InChI Key: LCLACFWVCLPCIQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
21.6762 -18.4372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5881 -19.2476 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0127 -17.1399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0128 -17.9571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2356 -18.2078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7554 -17.5487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2355 -16.8854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2074 -15.0406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4983 -14.6321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7893 -15.0408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7894 -15.8579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4985 -16.2664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2075 -15.8578 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9848 -16.1082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4649 -15.4490 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.9846 -14.7858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2351 -14.0085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0342 -13.8387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2847 -13.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7365 -12.4558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9346 -12.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.6878 -13.4072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5816 -14.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3299 -15.2229 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
3 7 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 1 0
14 15 2 0
15 16 1 0
13 14 1 0
8 16 2 0
16 17 1 0
7 14 1 0
1 4 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
23 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 320.35Molecular Weight (Monoisotopic): 320.1161AlogP: 3.25#Rotatable Bonds: 4Polar Surface Area: 70.90Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.69CX Basic pKa: 4.67CX LogP: 1.91CX LogD: 1.91Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.61Np Likeness Score: -0.56
References 1. Fuse S, Ohuchi T, Asawa Y, Sato S, Nakamura H.. (2016) Development of 1-aryl-3-furanyl/thienyl-imidazopyridine templates for inhibitors against hypoxia inducible factor (HIF)-1 transcriptional activity., 26 (24): [PMID:27847273 ] [10.1016/j.bmcl.2016.11.009 ]